Yahoo! News: Weight Loss News |
Anti-obesity product safe in mid-stage study (Reuters) Posted: 09 Jul 2009 04:36 PM PDT Reuters - Amylin Pharmaceuticals Inc said on Thursday a mid-stage study of its combination obesity product involving versions of hormones linked to appetite and metabolism yielded positive results. |
Amylin obesity treatment trial fails to impress (Reuters) Posted: 09 Jul 2009 12:10 PM PDT Reuters - Amylin Pharmaceuticals Inc said on Thursday a mid-stage study of its combination obesity treatment yielded positive results, but investors were unimpressed and the company's stock rose just 1 percent. |
You are subscribed to email updates from Yahoo! News: Weight Loss News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Inbox too full? | |
Google Inc., 20 West Kinzie, Chicago IL USA 60610 |
No comments:
Post a Comment